Cryo-Cell International, Inc. CCEL
Set alert
5.21 USD +0.03 +0.48%
At close · Oct 30
5.21 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
5.05 Day range 5.21
2.89 52-week range 5.21
- YTD
- +51.45%
- 1 year
- +16.04%
- Open
- 5.10
- Prev close
- 5.19
- Mkt cap
- 42.01M
- Vol
- 12.04K
- Avg vol
- 24.40K
- EPS
- -0.24
- P/E
- 0.00
- Div yield
- 12.77%
More statistics
- Low
- 5.05
- High
- 5.21
- Forward P/E
- 96.63
- Beta
- 0.51
- Short ratio
- 0.51
- Inst. own
- 11.18%
- Dividend
- 1.00
- Ex-div date
- Nov 14, 2024
- 50-d avg
- 7.71
- 200-d avg
- 7.47
- 1y target
- 9.00
Financial health
Altman Z-Score
-0.05 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 4
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -13.3×
FY 2016 5y median 13.2× FY 2025
P/S 1.0×
FY 2016 5y median 1.4× FY 2025
P/B -1.7×
FY 2016 5y median -4.0× FY 2025
P/FCF 6.1×
FY 2016 5y median 29.3× FY 2025
EV/EBITDA 39.5×
FY 2016 5y median 17.9× FY 2025
EV/Sales 1.4×
FY 2016 5y median 1.8× FY 2025
FCF Yield 16.3%
FY 2016 5y median 2.9% FY 2025
Profitability
Gross Margin 76.6%
FY 2016 5y median 73.1% FY 2025
Operating Margin 15.3%
FY 2016 5y median 13.3% FY 2025
Net Margin -7.7%
FY 2016 5y median 1.3% FY 2025
ROE 13.1%
FY 2016 5y median 13.1% FY 2025
ROIC 10.8%
FY 2016 5y median 7.0% FY 2025
ROA -3.9%
FY 2016 5y median 0.6% FY 2025
Growth (YoY)
Revenue -1.3%
FY 2016 FY 2025
Operating Income 39.1%
FY 2016 FY 2025
EPS (diluted) -700.0%
FY 2016 FY 2025
Free Cash Flow 118.0%
FY 2016 FY 2025
Financial Health
Current Ratio 0.6×
FY 2016 5y median 0.6× FY 2025
Quick Ratio 0.6×
FY 2016 5y median 0.6× FY 2025
Debt / Equity -0.6×
FY 2016 5y median -1.0× FY 2025
Net Debt / EBITDA 10.2×
FY 2016 5y median 1.5× FY 2025
Interest Coverage 2.3×
FY 2016 5y median 2.3× FY 2025
Dividends
Dividend Yield 10.1%
FY 2016 5y median 2.9% FY 2025
Payout Ratio -133.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-11-30